GlassScriptPhysician profile
Margaret J Dailey
NPI 1710706908
$2,415.00
in general payments reported to CMS, 2019-2025
22 companies · $2,326 in 2025
The $2,326 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $89.05 · 2025: $2,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,400 · Education: $15.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,399.96 |
| Education | $15.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $478.07 | 2024-2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $340.99 | 2024-2025 | Korlym |
| Tandem Diabetes Care, INC. | $256.11 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $238.49 | 2025 | Evenity, Prolia |
| Ibsa Pharma INC. | $140.21 | 2025 | Flector, Tirosint, Licart |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.27 | 2025 | Jardiance |
| Abbvie INC. | $107.42 | 2025 | |
| Lilly USA, LLC | $97.79 | 2025 | Zepbound, Mounjaro |
| Madrigal Pharmaceuticals | $86.78 | 2025 | Rezdiffra |
| Antares Pharma, INC. | $81.38 | 2025 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $78.66 | 2025 | |
| Averitas Pharma INC. | $64.40 | 2025 | Qutenza |
| Dexcom, INC. | $62.26 | 2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $41.25 | 2025 | |
| Sanofi-Aventis U.S. LLC | $36.19 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $30.12 | 2025 | NP Thyroid 60 |
| Medtronic, INC. | $29.91 | 2025 | Minimed 780g |
| Alexion Pharmaceuticals, INC. | $28.25 | 2025 | Strensiq |
| Abbott Laboratories | $28.25 | 2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $24.85 | 2025 | Gvoke Hypopen |
| Mannkind Corporation | $13.56 | 2025 | |
| Beta Bionics, INC. | $12.79 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Dailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.